Pfizer’s COVID vaccine has been approved for European children aged 12 to 15.
The European Medicines Agency (EMA) said Friday that the COVID-19 shot, developed by Pfizer and BioNTech, has been approved for children aged 12 to 15.
According to Marco Cavaleri, the chairman of the EMA panel that assessed Pfizer and BioNTech’s vaccines, the agency approved the shot for younger people after receiving the requisite evidence to demonstrate the vaccine’s effectiveness. According to Cavaleri, the European Commission and state authorities must still approve the EMA’s decision.
This is a developing story, and more information will be added as it becomes available.
Washington Newsday is committed to providing accurate and trustworthy immunization and health information in collaboration with NewsGuard. Users can use NewsGuard’s HealthGuard browser extension to see if a website is a reliable source of health information. To learn more and download the HealthGuard browser plugin, go to the Washington Newsday VaxFacts website.